CD69 and head and neck squamous cell carcinoma: Increased presence of activated (CD4+CD69+) and regulatory (CD4+FoxP3+) T helper cells were both associated with better outcomes of HNSCC, better prognosis and better locoregional control of the disease, respectively [26].